Members Login
Channels
Special Offers & Promotions
AMSBIO and Chondrex Cooperate On Arthritis & Inflammation Research
AMSBIO has announced a pan
European partnership with Chondrex Inc. to market their high quality arthritis
and inflammation reagents to academics and pharmaceutical companies that do
research in these fields.
The range includes a suite of high quality reagents such as highly purified cartilage collagen and collagen monoclonal antibodies to provide scientists with the necessary tools to study the pathogenesis as well as to develop and screen potential therapeutics for Rheumatoid Arthritis (RA). In addition, AMSBIO has also improved its capability to provide reagents and various assay kits for the investigation of other important inflammatory diseases such as nephritis and allergic asthma.
Multi species Collagen reactive antibodies are available that can be used in western blotting, immunostaining and for inducing Collagen Antibody-Induced Arthritis (CAIA).
Collagenases, members of the matrix metalloproteinase (MMP) family, are involved in the physiological and pathological turnover of connective tissues. Collagenase production is significantly increased at the sites of inflammation due to the stimulation of pro-inflammatory cytokines. AMSBIO is now able to provide recombinant human MMP-8 and MMP-13, in addition to collagenase assay kits using FITC-labeled type I collagen and type II collagen, or a fluorogenic peptide as substrates. The new AMSBIO arthritis & inflammation research reagent range also includes type I and type II collagen specially purified for antibody assay by ELISA.
For a catalogue detailing this exciting new range of high quality reagents for arthritis & inflammation research please visit http://www.amsbio.com/partners_chondrex.aspx or contact AMSBIO on +44-1235-828200 / +1-949-768-8365 or email info@amsbio.com
Founded in 1987, AMS Biotechnology (AMSBIO) is recognized as a leading international provider of unique innovative products & custom services for life sciences research. The AMSBIO range includes over 23,000 polyclonal & monoclonal antibodies, peptides, recombinant proteins, extracellular matrix, molecular detection reagents, & tissue DNA, RNA, protein & microarray products. Key research areas include: apoptosis, cell invasion & migration, cell signaling, DNA damage, 3D culture, electrophoresis, glycobiology, post-translational modification & stem cell biology.
The range includes a suite of high quality reagents such as highly purified cartilage collagen and collagen monoclonal antibodies to provide scientists with the necessary tools to study the pathogenesis as well as to develop and screen potential therapeutics for Rheumatoid Arthritis (RA). In addition, AMSBIO has also improved its capability to provide reagents and various assay kits for the investigation of other important inflammatory diseases such as nephritis and allergic asthma.
Multi species Collagen reactive antibodies are available that can be used in western blotting, immunostaining and for inducing Collagen Antibody-Induced Arthritis (CAIA).
Collagenases, members of the matrix metalloproteinase (MMP) family, are involved in the physiological and pathological turnover of connective tissues. Collagenase production is significantly increased at the sites of inflammation due to the stimulation of pro-inflammatory cytokines. AMSBIO is now able to provide recombinant human MMP-8 and MMP-13, in addition to collagenase assay kits using FITC-labeled type I collagen and type II collagen, or a fluorogenic peptide as substrates. The new AMSBIO arthritis & inflammation research reagent range also includes type I and type II collagen specially purified for antibody assay by ELISA.
For a catalogue detailing this exciting new range of high quality reagents for arthritis & inflammation research please visit http://www.amsbio.com/partners_chondrex.aspx or contact AMSBIO on +44-1235-828200 / +1-949-768-8365 or email info@amsbio.com
Founded in 1987, AMS Biotechnology (AMSBIO) is recognized as a leading international provider of unique innovative products & custom services for life sciences research. The AMSBIO range includes over 23,000 polyclonal & monoclonal antibodies, peptides, recombinant proteins, extracellular matrix, molecular detection reagents, & tissue DNA, RNA, protein & microarray products. Key research areas include: apoptosis, cell invasion & migration, cell signaling, DNA damage, 3D culture, electrophoresis, glycobiology, post-translational modification & stem cell biology.
Media Partners